402 filings
Page 11 of 21
6-K
SPRC
SciSparc Ltd
31 Dec 20
Report of Foreign Private Issuer
2:02pm
6-K
SPRC
SciSparc Ltd
15 Dec 20
Report of Foreign Private Issuer
10:55am
SC 13G
Eide Robert J
9 Dec 20
Therapix Biosciences / EIDE ROBERT J ownership change
5:11pm
6-K
SPRC
SciSparc Ltd
8 Dec 20
Therapix Biosciences Announces Upgrade to OTCQB Venture Market
9:36am
SC 13D/A
L.I.A. Pure Capital Ltd
3 Dec 20
Therapix Biosciences / L.I.A. Pure Capital ownership change
10:43am
6-K
SPRC
SciSparc Ltd
2 Dec 20
Special General Meeting of Shareholders
4:02pm
6-K
SPRC
SciSparc Ltd
2 Dec 20
Therapix Biosciences to Collaborate with The University of Calgary to Further Examine its Proprietary Drug Candidate THX-160 for Pain
9:25am
SC 13G
SPRC
SciSparc Ltd
30 Nov 20
Therapix Biosciences / BIGGER CAPITAL FUND L P ownership change
5:01pm
6-K
SPRC
SciSparc Ltd
24 Nov 20
Therapix Biosciences Announces Pricing of $4.2 Million Offering
1:13pm
424B4
SPRC
SciSparc Ltd
20 Nov 20
Prospectus supplement with pricing info
4:43pm
F-1MEF
SPRC
SciSparc Ltd
19 Nov 20
Registration statement to add securities to prior F-1 registration
9:33am
EFFECT
SPRC
SciSparc Ltd
19 Nov 20
Notice of effectiveness
12:15am
CORRESP
SPRC
SciSparc Ltd
16 Nov 20
Correspondence with SEC
12:00am
CORRESP
SPRC
SciSparc Ltd
12 Nov 20
Correspondence with SEC
12:00am
FWP
SPRC
SciSparc Ltd
5 Nov 20
Free writing prospectus
5:11pm
F-1/A
SPRC
SciSparc Ltd
4 Nov 20
Registration statement (foreign) (amended)
2:14pm
FWP
SPRC
SciSparc Ltd
21 Oct 20
Free writing prospectus
7:26am
F-1/A
SPRC
SciSparc Ltd
20 Oct 20
Registration statement (foreign) (amended)
9:57pm
6-K
SPRC
SciSparc Ltd
16 Oct 20
Report of Foreign Private Issuer
4:05pm
6-K
SPRC
SciSparc Ltd
14 Oct 20
Current report (foreign)
4:02pm